LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2015

Mar 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2015-03-02

Reporting Person: Lapuerta Pablo (EVP and CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-02	Common Stock	M	13000	—	Acquired	39783	Direct
2015-03-02	Common Stock	M	17500	—	Acquired	57283	Direct
2015-03-02	Common Stock	M	19750	—	Acquired	77033	Direct
2015-03-02	Common Stock	F	18266	$.94	Disposed	58767	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-02	Restricted Stock Units (Phantom Stock)	$	M	13000	Disposed		Common Stock (13000)	Direct
2015-03-02	Restricted Stock Units (Phantom Stock)	$	M	17500	Disposed		Common Stock (17500)	Direct
2015-03-02	Restricted Stock Units (Phantom Stock)	$	M	19750	Disposed		Common Stock (19750)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.

F3: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2013 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.

F4: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2014 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.

F5: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.